Advertisement
AMGN or LLY or PFE
AMGN | LLY | PFE | ||
|---|---|---|---|---|
OUTLOOK RATING 1..100 | 77 | 30 | 28 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 8 Undervalued | 51 Fair valued | 20 Undervalued | |
PROFIT vs RISK RATING 1..100 | 9 | 11 | 100 | |
SMR RATING 1..100 | 15 | 14 | 83 | |
PRICE GROWTH RATING 1..100 | 44 | 44 | 46 | |
P/E GROWTH RATING 1..100 | 27 | 58 | 5 | |
SEASONALITY SCORE 1..100 | 85 | 31 | 65 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AMGN's Valuation (8) in the Biotechnology industry is in the same range as PFE (20) in the Pharmaceuticals Major industry, and is somewhat better than the same rating for LLY (51) in the Pharmaceuticals Major industry. This means that AMGN's stock grew similarly to PFE’s and somewhat faster than LLY’s over the last 12 months.
AMGN's Profit vs Risk Rating (9) in the Biotechnology industry is in the same range as LLY (11) in the Pharmaceuticals Major industry, and is significantly better than the same rating for PFE (100) in the Pharmaceuticals Major industry. This means that AMGN's stock grew similarly to LLY’s and significantly faster than PFE’s over the last 12 months.
LLY's SMR Rating (14) in the Pharmaceuticals Major industry is in the same range as AMGN (15) in the Biotechnology industry, and is significantly better than the same rating for PFE (83) in the Pharmaceuticals Major industry. This means that LLY's stock grew similarly to AMGN’s and significantly faster than PFE’s over the last 12 months.
LLY's Price Growth Rating (44) in the Pharmaceuticals Major industry is in the same range as AMGN (44) in the Biotechnology industry, and is in the same range as PFE (46) in the Pharmaceuticals Major industry. This means that LLY's stock grew similarly to AMGN’s and similarly to PFE’s over the last 12 months.
PFE's P/E Growth Rating (5) in the Pharmaceuticals Major industry is in the same range as AMGN (27) in the Biotechnology industry, and is somewhat better than the same rating for LLY (58) in the Pharmaceuticals Major industry. This means that PFE's stock grew similarly to AMGN’s and somewhat faster than LLY’s over the last 12 months.
| AMGN | LLY | PFE | |
|---|---|---|---|
| RSI ODDS (%) | 1 day ago 63% | 1 day ago 74% | 1 day ago 56% |
| Stochastic ODDS (%) | 1 day ago 57% | 1 day ago 74% | 1 day ago 56% |
| Momentum ODDS (%) | 1 day ago 49% | 1 day ago 63% | 1 day ago 54% |
| MACD ODDS (%) | 1 day ago 65% | 1 day ago 73% | 1 day ago 58% |
| TrendWeek ODDS (%) | 1 day ago 49% | 1 day ago 59% | 1 day ago 56% |
| TrendMonth ODDS (%) | 1 day ago 47% | 1 day ago 58% | 1 day ago 54% |
| Advances ODDS (%) | 9 days ago 61% | 1 day ago 70% | 10 days ago 54% |
| Declines ODDS (%) | 1 day ago 47% | 6 days ago 55% | 3 days ago 56% |
| BollingerBands ODDS (%) | 1 day ago 69% | N/A | 1 day ago 52% |
| Aroon ODDS (%) | 1 day ago 48% | 1 day ago 72% | 1 day ago 60% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AMGN’s FA Score shows that 4 FA rating(s) are green while LLY’s FA Score has 2 green FA rating(s), and PFE’s FA Score reflects 2 green FA rating(s).
- AMGN’s FA Score: 4 green, 1 red.
- LLY’s FA Score: 2 green, 3 red.
- PFE’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AMGN’s TA Score shows that 6 TA indicator(s) are bullish while LLY’s TA Score has 3 bullish TA indicator(s), and PFE’s TA Score reflects 3 bullish TA indicator(s).
- AMGN’s TA Score: 6 bullish, 4 bearish.
- LLY’s TA Score: 3 bullish, 6 bearish.
- PFE’s TA Score: 3 bullish, 5 bearish.
Price Growth
AMGN (@Pharmaceuticals: Major) experienced а -4.97% price change this week, while LLY (@Pharmaceuticals: Major) price change was -2.29% , and PFE (@Pharmaceuticals: Major) price fluctuated -4.25% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.53%. For the same industry, the average monthly price growth was -5.23%, and the average quarterly price growth was +8.35%.
Reported Earning Dates
AMGN is expected to report earnings on Nov 03, 2026.
LLY is expected to report earnings on Oct 29, 2026.
PFE is expected to report earnings on Nov 03, 2026.
Industries' Descriptions
@Pharmaceuticals: Major (-1.53% weekly)The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
Advertisement
LLY and
Correlation & Price change
A.I.dvisor indicates that over the last year, LLY has been loosely correlated with JNJ. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if LLY jumps, then JNJ could also see price increases.
PFE and
Correlation & Price change
A.I.dvisor indicates that over the last year, PFE has been loosely correlated with BMY. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if PFE jumps, then BMY could also see price increases.
| Ticker / NAME | Correlation To PFE | 1D Price Change % | ||
|---|---|---|---|---|
| PFE | 100% | +0.33% | ||
| BMY - PFE | 57% Loosely correlated | +1.33% | ||
| MRK - PFE | 55% Loosely correlated | +1.72% | ||
| AMGN - PFE | 52% Loosely correlated | -0.09% | ||
| BIIB - PFE | 48% Loosely correlated | -0.31% | ||
| NVS - PFE | 47% Loosely correlated | -0.10% | ||
More | ||||